Physician profile
Nathaniel L Griffith
NPI 1811918766
$7,369.39
in general payments reported to CMS, 2019-2025
11 companies · $790 in 2025
The $790 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,202 · 2020: $733 · 2021: $1,377 · 2022: $1,318 · 2023: $1,195 · 2024: $755 · 2025: $790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,740.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $4,717.69 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $802.73 | 2022-2025 | |
| Lilly USA, LLC | $685.14 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $449.24 | 2023-2024 | Arexvy, Shingrix, Trelegy Ellipta |
| Novartis Pharmaceuticals Corporation | $170.43 | 2019 | |
| Sanofi-Aventis U.S. LLC | $135.93 | 2019 | |
| Novo Nordisk INC | $129.73 | 2020 | |
| Incyte Corporation | $123.29 | 2021 | |
| Radius Health, INC. | $110.55 | 2019 | |
| Abbott Laboratories | $29.33 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.33 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathaniel Griffith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.